Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea
· Delayed Price · Currency is KRW
101,500
+7,500 (7.98%)
At close: Apr 29, 2026
Curiox Biosystems Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,737,663 | 2,003,020 | 299,264 | 403,531 | - | - | |
| Market Cap Growth | 487.67% | 569.32% | -25.84% | - | - | - | |
| Enterprise Value | 1,722,332 | 1,984,438 | 276,962 | 383,796 | - | - | |
| Last Close Price | 101500.00 | 117000.00 | 18560.00 | 25150.00 | - | - | |
| PS Ratio | 337.31 | 388.82 | 65.23 | 59.45 | - | - | |
| PB Ratio | 32.90 | 37.93 | 6.15 | 7.63 | - | - | |
| P/TBV Ratio | 103.08 | 118.82 | 23.66 | 20.93 | - | - | |
| EV/Sales Ratio | - | 385.21 | 60.37 | 56.54 | - | - | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.17 | 0.02 | 0.01 | 1.40 | |
| Net Debt / Equity Ratio | -0.29 | -0.29 | -0.41 | -0.32 | -0.19 | 0.49 | |
| Net Debt / EBITDA Ratio | 1.62 | 1.62 | 1.86 | 1.97 | 0.85 | -1.50 | |
| Net Debt / FCF Ratio | 1.36 | 1.36 | 2.01 | 2.02 | 0.78 | -1.97 | |
| Asset Turnover | 0.07 | 0.07 | 0.07 | 0.13 | 0.14 | 0.11 | |
| Inventory Turnover | 1.74 | 1.74 | 1.19 | 1.31 | 1.07 | 1.72 | |
| Quick Ratio | 0.85 | 0.85 | 1.45 | 7.26 | 3.75 | 0.66 | |
| Current Ratio | 1.72 | 1.72 | 1.62 | 7.95 | 4.92 | 0.71 | |
| Return on Equity (ROE) | -53.58% | -53.58% | -15.94% | -20.76% | -35.07% | -60.04% | |
| Return on Assets (ROA) | -10.36% | -10.36% | -13.03% | -12.40% | -13.67% | -10.72% | |
| Return on Capital Employed (ROCE) | -22.50% | -22.50% | -26.40% | -19.20% | -24.90% | -35.50% | |
| Earnings Yield | -1.56% | -1.36% | -2.70% | -2.49% | - | - | |
| FCF Yield | -0.65% | -0.56% | -3.33% | -2.08% | - | - | |
| Buyback Yield / Dilution | -2.73% | -2.73% | -12.50% | -101.43% | 45.55% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.